India Drugmaker Cipla Cuts Prices of Generic Drug

By Lissette Talledo

Indian drugmaker Cipla has cut the generic version of Bayer’s Nevaxar by 75 percent. These are lung and brain cancer drugs which will be sold at 6,840 Rupees a month.

That is compared to how much Bayer sells these drugs for at 284, 428 per month.

Cipla says they do not expect these price cuts will affect their revenue. The products already have low volumes.

The reason for their decision is to make these drugs more affordable to patients.

Bayer is suing Cipla for patent infringement over Nexavar in court.

This occurred two months after India decided to allow another drugmaker to make a cheaper version of drugs despite Bayer’s objections.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: